Literature DB >> 29034355

Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Jasmine H Francis1,2, Larissa A Habib1, David H Abramson1,2.   

Abstract

Entities:  

Keywords:  electroretinogram; intravitreous chemotherapy; melphalan; retinoblastoma; vitreal seeds; vitreous seeds

Year:  2017        PMID： 29034355      PMCID： PMC5635842          DOI： 10.1016/j.yaoo.2017.03.008

Source DB:  PubMed          Journal:  Adv Ophthalmol Optom


× No keyword cloud information.
  31 in total

1.  Present therapeutic resources in retinoblastoma.

Authors:  L A ERICSON; B H ROSENGREN
Journal:  Acta Ophthalmol (Copenh)       Date:  1961

2.  Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.

Authors:  Jasmine H Francis; Scott E Brodie; Brian Marr; Emily C Zabor; Ijah Mondesire-Crump; David H Abramson
Journal:  Ophthalmology       Date:  2017-01-12       Impact factor: 12.079

3.  Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectives.

Authors:  Francis L Munier; Marie-Claire Gaillard; Aubin Balmer; Maja Beck-Popovic
Journal:  Saudi J Ophthalmol       Date:  2013-07

4.  Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir.

Authors:  Patricia Chévez-Barrios; Murali Chintagumpala; William Mieler; Evelyn Paysse; Milton Boniuk; Claudia Kozinetz; Mary Y Hurwitz; Richard L Hurwitz
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

5.  Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.

Authors:  Fariba Ghassemi; Carol L Shields; Hadi Ghadimi; Alireza Khodabandeh; Ramak Roohipoor
Journal:  JAMA Ophthalmol       Date:  2014-08       Impact factor: 7.389

6.  Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.

Authors:  Francis L Munier; Marie-Claire Gaillard; Aubin Balmer; Sameh Soliman; Gregory Podilsky; Alexandre P Moulin; Maja Beck-Popovic
Journal:  Br J Ophthalmol       Date:  2012-06-13       Impact factor: 4.638

7.  Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.

Authors:  Jasmine H Francis; Paula Schaiquevich; Emiliano Buitrago; María José Del Sole; Gustavo Zapata; J Oscar Croxatto; Brian P Marr; Scott E Brodie; Alejandro Berra; Guillermo L Chantada; David H Abramson
Journal:  Ophthalmology       Date:  2014-05-10       Impact factor: 12.079

8.  Cytopathological Evaluation of Ocular Surface and Needle Washings Following Intravitreal Melphalan Injections for Retinoblastoma.

Authors:  Jasmine H Francis; Ijah Mondesire-Crump; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-02-04       Impact factor: 1.402

9.  Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013.

Authors:  Francis L Munier
Journal:  Ophthalmic Genet       Date:  2014-10-16       Impact factor: 1.803

10.  Death by water: precautionary water submersion for intravitreal injection of retinoblastoma eyes.

Authors:  Jasmine H Francis; Xiaoliang L Xu; Y Pierre Gobin; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  Open Ophthalmol J       Date:  2014-05-16
View more
  1 in total

1.  Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.

Authors:  Lucy V Cobbs; Jasmine H Francis; Ira J Dunkel; Y Pierre Gobin; Scott E Brodie; David H Abramson
Journal:  Pediatr Blood Cancer       Date:  2020-12-23       Impact factor: 3.838
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.